P4A Let’s Talk Rare: The Life Science Podcast
In the latest episode of Let’s Talk Rare, Owen Bryant & Georgie Rack delve into the world of drug development in rare diseases. They are
April 28, 2025
News
Orphan Therapeutics Accelerator Announces Foundational Partnerships
Originally published on Business Wire BOSTON–(BUSINESS WIRE)–The Orphan Therapeutics Accelerator (OTXL), a non-profit biotech organization focused on completing development and commercializing therapies for ultra-rare conditions,
April 23, 2025
Transformation in Trials
Rob Freistat, President of Uncommon Cures, discusses how clinical trials are transforming to accelerate drug development and ensure patients receive treatments faster, particularly in the
April 23, 2025
A New Approach to Rare Disease Clinical Trials
Originally published on Triple Pundit Research studies that test potential treatments for rare diseases have long faced excessive costs, prolonged timelines and a staggering failure
April 10, 2025
The United States: Global Leadership in the Development of Rare Disease Treatments
In an era of healthcare reform and heightened scrutiny of pharmaceutical innovation, America’s leadership in rare disease drug development stands out as a remarkable achievement.
February 28, 2025
Innovations in research and treatment for rare diseases
We discuss the latest efforts to advance medical research, the new possibilities spurred by artificial intelligence and the critical role of caregivers. https://www.washingtonpost.com/video/washington-post-live/rare-diseases-presented-by-harmony-biosciences/2025/02/27/fdd36eea-84a5-4166-b435-f6c7e307d8d1_video.html
February 27, 2025